Related Experiment Video
Updated: Nov 16, 2025

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
Published on: September 20, 2024
Immunosuppression as a risk factor for COVID-19: a meta-analysis
Daniel Tassone1, Alexander Thompson1, William Connell1
1Department of Gastroenterology, St Vincent's Hospital, Melbourne, Victoria, Australia.
Immunosuppressed patients do not face a significantly higher risk of COVID-19 infection compared to the general population. Current recommendations to continue immunosuppressant therapy are supported by this evidence.
Area of Science:
- Immunology
- Infectious Diseases
- Public Health
Background:
- Immunosuppression theoretically increases COVID-19 risk, but this relationship requires clarification.
- Understanding this risk is crucial for managing patients on immunosuppressants during the pandemic.
Purpose of the Study:
- To determine if immunosuppressed individuals have a higher risk of contracting COVID-19.
- To inform clinical management strategies for immunosuppressant therapies amidst the pandemic.
Main Methods:
- A random-effects meta-analysis was conducted.
- Data from six studies, encompassing 10,049 patients with COVID-19, were analyzed.
- Prevalence of immunosuppression in COVID-19 cohorts was compared to the general population using observed to expected ratios.
Main Results:
- The pooled prevalence of immunosuppression among COVID-19 patients was 0.637%.
- The observed to expected ratio of immunosuppression in COVID-19 patients was 0.12 (95% CI: 0.05-0.27).
- This indicates a lower-than-expected prevalence of immunosuppression in COVID-19 cohorts.
Conclusions:
- Immunosuppressed patients are not at a significantly increased risk of COVID-19 infection compared to the general population.
- Findings support current guidelines recommending the continuation of immunosuppressant therapy for patients without active COVID-19.
Related Concept Videos
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Psychoneuroimmunology: Diabetes and Cancer
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...

